Novartis
NVS
938 hedge funds and large institutions have $22.2B invested in Novartis in 2017 Q3 according to their latest regulatory filings, with 70 funds opening new positions, 348 increasing their positions, 336 reducing their positions, and 44 closing their positions.
86% more call options, than puts
Call options by funds: $41.3M | Put options by funds: $22.2M
59% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 44
2% more funds holding
Funds holding: 921 → 938 (+17)
4% more repeat investments, than reductions
Existing positions increased: 348 | Existing positions reduced: 336
2% more capital invested
Capital invested by funds: $21.7B → $22.2B (+$474M)
0.06% less ownership
Funds ownership: 11.09% → 11.03% (-0.06%)
5% less funds holding in top 10
Funds holding in top 10: 40 → 38 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$158M |
| 2 |
Parnassus Investments
San Francisco,
California
|
+$124M |
| 3 |
Millennium Management
New York
|
+$63.5M |
| 4 |
Morgan Stanley
New York
|
+$41.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
-$464M |
| 2 |
SEI Investments
Oaks,
Pennsylvania
|
-$32.2M |
| 3 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
-$31.6M |
| 4 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$18.3M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$16M |
NVS Hedge Fund Activity: Q3 2017 in Review
938 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q3 2017, worth a combined $22.2B — up 2.2% from $21.7B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new NVS positions and 44 closed out — a net gain of 26 holders — while 348 added to existing stakes and 336 trimmed.
The largest buyer was Bank of America, adding an estimated $158M. The largest seller was Dodge & Cox, cutting an estimated $464M.
- 938 institutional investors held Novartis (NVS) as of Q3 2017, up from 921 in Q2 2017.
- Funds reported $22.2B of Novartis stock for Q3 2017, up 2.2% quarter-over-quarter.
- 70 funds opened new Novartis positions in Q3 2017 and 44 closed out, a net change of +26 holders.
- The largest Novartis buyer in Q3 2017 was Bank of America, an estimated $158M added.
- The largest Novartis seller in Q3 2017 was Dodge & Cox, an estimated $464M sold.
Based on aggregated 13F filings for Q3 2017.